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Abstract: 
 Ataxia-telangiectasia (A-T) is a progressive neurodegenerative disorder with 
prominent eye movement deficits localizing to the cerebellum. We sought to determine if 
4-aminopyridine (4-AP) that putatively enhances the precision of Purkinje neurons, 
could improve the disorders of eye movements and vestibular function in A-T.  
The influence of 4-AP on disorders of eye movements and vestibular function 
was studied in four A-T patients.  The effects on the cerebellar control of vestibulo-
ocular reflex (VOR) was quantitatively assessed by the decay time constant of per- and 
post-rotational nystagmus during constant velocity en bloc rotations. The length of the 
VOR time constant determines the fidelity of the vestibular velocity storage, a neural 
mechanism that increases the bandwidth of VOR under cerebellar control.  The VOR 
time constant was not increased in A-T patients.  Latter is explained by the extent of 
cerebellar lesion as previously described in A-T and other cerebellar disorders.  
Nevertheless, 4-AP shortened the VOR time constant during horizontal rotations. 
Severe disinhibition of velocity storage in subjects with putatively profound cerebellar 
degeneration manifest periodic alternating nystagmus (PAN).  Among two A-T subjects 
who manifested PAN, 4-AP reduced the peak slow-phase velocity of the more severely 
affected individual and abrogated the PAN in the other. Two A-T subjects manifested 
horizontal and vertical spontaneous nystagmus (SN) in primary gaze, 4-AP reduced its 
slow-phase velocity.   
We conclude that in subjects with A-T 4-AP has a prominent effect on the ocular 
motor and vestibular deficits that are ascribed to the loss of cerebellar Purkinje neurons.  
  
 
Introduction: 
 Ataxia-telangiectasia (A-T) is an autosomal recessive disorder characterized by 
neural degeneration, immunodeficiency, radiosensitivity, and enhanced risk of chiefly 
lymphoreticular malignancy. Neuropathologic features found in individuals with A-T are 
focused in the cerebellar cortex, with diffuse loss of Purkinje and granule cells. Early 
investigators thus classified this disease as a cerebellar ataxia syndrome and gave A-T 
its iconic name [1, 4, 6-8, 13, 23]. Many of the neurologic deficits apparent in individuals 
with A-T, such as gaze-evoked nystagmus, periodic alternating nystagmus (PAN), 
ocular motor apraxia, impaired smooth pursuit, saccadic dysmetria, ataxia, and kinetic 
tremor, point to degeneration of the cerebellar cortex [4, 7, 20, 24, 25, 32, 33].  
We sought to determine if 4-aminopyridine (4-AP) can improve the deficits of eye 
movement and vestibular function in subjects with A-T. 4-AP is a blocker of inward 
rectifier potassium currents [11]. One proposed consequence of 4-AP treatment is 
facilitation of synchrony and thus greater precision of Purkinje neuron discharge [2].  An 
effect on discharge precision may facilitate the synaptic release of the inhibitory 
neurotransmitter gamma-aminobutyric acid (GABA) at Purkinje neuron projection sites 
[2, 14, 16, 29]. This mechanism has been offered as a possible explanation for how 4-
AP decreases the downbeat nystagmus in individuals having disorders of the 
cerebellum [14, 16, 29]. 
We hypothesized that 4-AP could improve the deficits that localize to the 
cerebellar cortex in A-T subjects.  
  
Methods: 
 Effects of 4-AP was assessed in four subjects with A-T. All four subjects had a 
mutation in the A-T associated ATM gene (McConville et al, 1996), and a diagnosis of 
A-T by accepted clinical criteria [9, 21]. Table 1 depicts the summary of their clinical 
presentation. Subjects were evaluated at the vertigo center and vestibulo-oculomotor 
laboratory of the University Hospital Zurich, Switzerland.  10 mg 4-AP, which was 
prescribed to the patients to decrease their cerebellar deficits, was first administered 
during the clinical visit. Its efficacy was assessed by quantitative measurements of the 
eye and limb movements and the VOR. The assessment protocol was approved by the 
local ethics committee. All subjects signed a written informed consent form.  
Experimental setup 
 Subjects were seated on a three-axis motor-driven turntable (Acutronic, Jona, 
Switzerland). The head was stabilized by a custom-molded thermoplastic mask (Sinmed 
BV, Reeuwijk, The Netherlands).  Three-dimensional eye movements were recorded 
with dual search coils (Skalar Instruments, Delft, The Netherlands). The search coil 
annuli were calibrated and then placed on the sclera after local anesthesia with 
oxybuprocaine 0.4% [5]. The coil frame around the head (side length: 0.5 m) generated 
three orthogonal digitally synchronized magnetic wave field signals at 80, 96 and 120 
kHz. A digital signal processor computed a fast Fourier transform in real time on the 
digitized search coil signal to determine the voltage induced on the coil by each 
magnetic field (system by Primelec, Regensdorf, Switzerland). Coil orientation could be 
determined with an error of less than 7% over a range of ±30°, and with a noise level of 
less than 0.05° (root mean squared deviation). Eye position signals were digitized at 
  
1,000 Hz per channel with 12-bit resolution. Calibrated eye position signals were 
processed with an interactive program (MatLab®; The Math Works, Natick, MA, USA). 
Eye positions were represented as 3D rotation vectors in a head-fixed coordinate 
system.  
Vestibulo-ocular reflex measurement  
The VOR was elicited during constant velocity en bloc rotations in a completely 
dark room. Rotation with an initial acceleration at 90º/s2 continued to a final speed of 
100º/s. Eye movements were then recorded for 90 seconds of rotation time. The 
turntable was then decelerated at 90º/s2 until it stopped, and eye movements were 
measured for 90 seconds. These rotational trials were done with the subject in three 
different positions. In an upright posture, the rotation primarily stimulated the horizontal 
semicircular canal (yaw rotation); rotations with the subject supine (roll rotation), or 
recumbent left ear down (pitch rotation), primarily stimulated the vertical canals. 
Because the rotations were around the earth vertical axis gravitational force applied to 
the inner ear remained constant. All rotations were in both directions (i.e. in head-
centered frame of reference right or left for yaw rotations, up or down for pitch rotations, 
and clockwise or counterclockwise for roll rotations). Each subject thus experienced at 
least six sets of constant velocity rotations, one in each direction of each of the three 
axes. Each trial was separated by a rest period of at least two minutes.  
Assessment of gaze-holding 
 Eye movements were recorded when the subjects attempted to hold gaze steady 
at straight ahead on space fixed laser target for at least two to three minutes. During 
  
assessment of gaze-holding function, the vestibular chair was secured such that the 
subject remained in the upright position.  
Data analysis 
Rotation vectors were smoothed, and angular eye velocity of nystagmus was 
computed as described previously [28]. The time constant of the decaying slow phase 
eye velocity was computed in steps. First, the slow-phase velocity of nystagmus versus 
time was plotted. Velocity was then fitted according to an exponential function. Least-
squares fitting algorithm (Matlab®, MathworksTM, Optimization Toolbox) was used to 
compute the exponential time constant that best fit the data.  
Median slow phase velocity of each nystagmus cycle was utilized to sample a 
cohort of slow phase velocities during given fixation trial.  The epochs of slow phase 
velocities for the given patient during horizontal, vertical, and torsional nystagmus was 
used to assess statistical significance of the drug effect; hence for the measurement of 
drug effect, each patient served as self-control.  In subjects with PAN, the slow phase 
eye velocity of nystagmus modulated in sinusoidal fashion.  Sinusoidal function was 
fitted to quantify the periodicity and the amplitude of PAN.  Peak to peak time 
determined the duration of period, while the peaks and trough values of the sinusoidal fit 
yielded maximum slow-phase velocities of PAN in each direction.  
  
Results: 
Effects of 4-AP on vestibulo-ocular reflex (VOR): 
VOR time constant 
We measured the effects of 4-AP on the decay time constant of the velocity 
storage to assess its influence on the VOR.  Parallel, direct and indirect, pathways 
guarantee efficient function of VOR [22].  The direct pathway, comprised of three-
neuron-arc, is responsible for rapid reflexive changes in eye velocity in response to 
head movement [3].  The indirect pathway features the neural integrator, the velocity 
storage, that stabilizes the eye velocity during whole field rotation and extends the 
band-width over which the VOR is compensatory for head movement [22].  Gamma-
aminobuteric acid (GABA) mediated inhibition through the Purkinje neurons of 
cerebellar nodulus and ventral uvula determines the fidelity of the velocity storage, its 
function is measured by the decay rate of the velocity storage output, the slow phase 
eye velocity of rotational nystagmus during en bloc constant velocity rotations [31].  It is 
therefore anticipated that cerebellar disease might affect the velocity storage, while 
drugs influencing the cerebellar function might affect the decay time constant of the 
velocity storage.  The drug that increases the inhibitory influence of Purkinje neurons, 
such as 4-AP, shortens the velocity storage time constant [26].  The velocity storage 
time constant is typically measured by assessing the rate of decay of slow-phase eye 
velocity of per-rotational nystagmus during en bloc constant velocity rotation.  The rate 
of decay of slow-phase eye velocity of post-rotational nystagmus immediately after the 
rotation is also used to measure the velocity storage time constant. 
  
 Figure 1 illustrates the effect of 4-AP on the slow-phase velocity of the rotational 
nystagmus in one subject.  The slow-phase velocity of the horizontal nystagmus during 
yaw rotations had an abrupt rise that was immediately followed by an exponential decay 
(Figure 1A). Before 4-AP the time constant of decay was 11 seconds (grey symbols, 
Figure 1A), while 30 minutes after taking 10 mg 4-AP the time constant was 8 seconds 
(open circles in Figure 1A). 
Figure 1B and 1C depict examples of torsional and vertical nystagmus during roll 
and pitch rotations around the earth-vertical axis. The slow-phase velocity of the 
torsional nystagmus during roll rotations decayed at a time constant of 6.8 seconds 
before 4-AP, the decay time constant was 6.5 seconds after 4-AP (Figure 1B). The 
decay time constant of vertical nystagmus during pitch rotations before and after 4-AP 
remained unchanged at 6.2 seconds (Figure 1C). 
The decay time constants of per- and post-rotational nystagmus were analyzed 
in three of the four subjects. One subject was excluded from this analysis because 
periodic alternating nystagmus (PAN) interfered with computation of decay time 
constant. Figure 2 depicts the summary, decay time constant before 4-AP is plotted 
along x-axis, while y-axis represents the decay time constant after 4-AP.  Each data 
point depicts one rotation trial, each symbol type depicts individual subject; the dashed 
line is an equality line.  Figure 2A illustrates summary of yaw rotations.  Circular and 
diamond shaped data points fall below the equality line, while triangular data points fall 
on the equality line.  These results suggest that 4-AP consistently reduced decay time 
constant of rotational nystagmus during yaw rotations in two subjects; in one subject 4-
AP had no effect.  Figure 2B depicts a summary of effects of 4-AP on decay time 
  
constant of torsional nystagmus during roll rotations.  All data points fall along the 
dashed equality line, suggesting lack of 4-AP effect on the decay time constant of 
torsional VOR.  Likewise 4-AP had no effect on decay time constant of vertical VOR 
evoked during pitch rotations, all data points in Figure 2C fell along the dashed equality 
line. 
The same technique to measure eye movements and the same parameters of 
vestibular stimuli in healthy subjects revealed mean horizontal VOR time constant at 
13.6 seconds with variance of 16.2 seconds [26].  The mean decay time constant for 
torsional and vertical VOR during roll and pitch rotations in healthy subjects were 6.3 
seconds and 7.8 seconds (variance: 1 second and 4.8 seconds), respectively [26].  As 
evident from the summary in Figure 2A, the decay time constant of horizontal, vertical 
and torsional VOR during yaw, pitch, and roll rotations were not increased.  The mean 
value of horizontal, vertical, and torsional VOR time constants were 9.2 ± 2.5 seconds, 
6.7 ± 1.2 seconds, and 5.8 ± 1.5 seconds, respectively.  4-AP reduced the population 
mean of horizontal VOR during yaw rotations to 6.4 ± 1.6 seconds (31.5% reduction), 
however, vertical and torsional VOR time constants had minimally changed to 6.5 ± 1.3 
seconds (3% reduction) and 5.2 ± 1.4 (9% reduction) seconds, respectively. 
VOR gain 
The VOR gain reflects the ratio of peak eye velocity to peak head velocity.  
Although ideal value of VOR gain should be one, in most healthy subjects the VOR gain 
in darkness is typically less than one. Using current experiment design and paradigms, 
the VOR gain in healthy subjects was 0.55 ± 0.2, 0.43 ± 0.14, and 0.34 ± 0.16 during 
yaw, pitch and roll rotations respectively [24, 26].  In A-T subjects however, the VOR 
  
gain is higher than healthy subjects [24].  VOR gain in our subjects was measured by 
computing the ratio of peak slow phase eye velocity immediately after the onset of head 
rotations and rotational head velocity.  Figure 3 illustrates the summary of VOR gain 
measured from A-T patients.  Each data point depicts the VOR gain during one rotation 
trial, circular symbols depict yaw rotation, square symbols are pitch rotation, while 
triangles depict roll rotation.  VOR gain measured after 4-AP is plotted on y-axis, while 
x-axis depicts the values of VOR gain during control condition.  Dashed line is an 
equality line.  All data points fall along the equality line. The slope of the fitted linear 
function relating the values of gain before and after 4-AP was 0.91.  The gain values 
before and after 4-AP intake significantly correlated (correlation coefficient: 0.89; p 
<0.0001). Mean VOR gain in our A-T subjects was 0.99 ± 0.13,  0.6 ± 0.14, and 0.47 ± 
0.09 during yaw, pitch and roll rotations respectively.  After administration of 4-AP the 
mean VOR gain was 1.01 ± 0.1,  0.7 ± 0.17, and 0.45 ± 0.08 during yaw, pitch and roll 
rotations, respectively.   
Effects of 4-AP on gaze holding – periodic alternating nystagmus (PAN) 
 Periodic alternating nystagmus (PAN) is a condition where the nystagmus 
changes direction in periodic manner.  The sequence of PAN includes nystagmus that 
beats on one side, transition period, reversal of beating direction, and then repetition of 
the sequence. PAN was present in two A-T subjects. The nystagmus was quantified by 
measuring median eye velocity during of each nystagmus slow-phase (e.g. each 
datapoint in Figure 4).  Median slow-phase velocity was then plotted with corresponding 
time, the periodic modulation of nystagmus resulted in sinusoidal shape (Figure 4).  The 
relationship of slow-phase velocity that modulated with time was then fitted with 
  
sinusoidal function.  The peak and trough value of sinusoid depicted peak slow-phase 
velocity of PAN in each direction, while inverse of fitted sinusoid frequency provided the 
duration of PAN.  Peak slow-phase velocity of PAN, before 4-AP, was 23 ± 4 º/second 
in subject 1 and 4.3 ± 3.0 º/second in subject 2. The periods were 16 ± 3 and 6 ± 3 
seconds in subjects 1 and 2, respectively. In subject 1, 4-AP reduced the peak slow-
phase eye velocity of PAN to 13 ± 1.3 º/second (43.5% reduction) but did not alter the 
duration of the period (Figure 4A). 4-AP resolved the PAN in subject 2 (Figure 4B). 
Effects of 4-AP on gaze holding –spontaneous nystagmus 
 Spontaneous nystagmus was present in all three axes.  Horizontal, vertical, and 
torsional nystagmus was quantified independently.  Median velocity of the slow phase of 
each nystagmus cycle was measured. The cohort of median slow phase velocity 
computed from multiple oscillatory cycles comprising nystagmus was then used for 
statistical comparison of the effects of 4-AP on nystagmus.  Analysis was done only on 
data collected when the subjects fixated gaze on straight ahead target.  Figure 5 
summarizes the slow-phase velocity of horizontal, vertical, and torsional nystagmus 
during straight-ahead fixation. This analysis was not done for either horizontal or vertical 
nystagmus in subject 1, or for horizontal nystagmus in subject 2, due to the confounding 
effects of PAN.  In Figure 5, each box and whisker plot depicts the summary of 
population comprising slow phase velocities from all nystagmus cycles in a given 
direction from one subject.  The horizontal line in the center of a notch depicts a 
population median, notch depicts 95% confidence interval, while the length of the box 
depicts interquartile interval.  4-AP reduced the slow-phase eye velocity of horizontal 
nystagmus in one of two (Figure 5A), and for vertical nystagmus in all three (Figure 5B) 
  
subjects (one-way ANOVA p < 0.05).  The subjects, in whom 4-AP had significant 
effects the notches of corresponding box-whisker plots (depicting populations of slow 
phase velocity before and after 4-AP), did not overlap (Figure 5A,B).  There is an 
overlap in notches of box and whisker plots comparing the populations of slow phase 
velocities before and after 4-AP (Figure 5C).  Latter suggested lack of 4-AP effect on 
the torsional nystagmus on any subject (one-way ANOVA, p > 0.05). 
 
  
Discussion: 
4-AP affects measures of impaired gaze holding and vestibular function in 
subjects with A-T.  These deficits have been attributed to reduced GABAergic inhibition 
upon the brainstem vestibular and deep cerebellar nuclei as a consequence of 
progressive degeneration of the cerebellar cortex. 4-AP is thought to be effective in 
cerebellar degenerations as a result of its ability to facilitate Purkinje cell output.  
A prominent feature of cerebellar control of eye movements is reflected in low-
frequency modulation of the VOR.  A ‘velocity-storage’ mechanism prolongs the decay 
of the per- and post-rotational nystagmus by means of GABA-mediated inhibitory 
control from the cerebellar Purkinje neurons in the posterior cerebellar vermis.  
Individuals with damage to this region, including those with A-T in whom Purkinje 
neuron dropout is pan-cerebellar, thus manifest disinhibited velocity storage.  When 
severe, disinhibition of velocity storage can manifest with PAN, which emerges in this 
state as a consequence of an adaptive vestibular mechanism that normally acts to 
minimize sustained unidirectional nystagmus, even to the point of causing the oscillating 
reversals of direction [12, 17, 18, 31].  Although we saw PAN in our subjects with A-T, 
we did not observe an increase in the VOR time constant. This observation is possible, 
as prolongation of VOR time constant might depend on the extent of lesion as 
previously reported in individuals with A-T and other cerebellar lesions [15, 24].  As 
expected, 4-AP reduced the duration of velocity storage time constant in subjects with 
A-T; the reduction was prominent for yaw rotations, while time constant during pitch and 
roll rotations were unaffected.  This observation is consistent with the effects of 4-AP on 
velocity storage time constant in healthy subjects [26]. It is predicted that lack of effects 
  
of 4-AP on time constant of torsion and vertical VOR is because of weak or absent 
contribution of velocity storage during rotation in vertical canal planes [30]. 
Typical duration of PAN is approximately four to five minutes [19].  The duration 
of PAN, however, relies on the adaptation time constant [18].  Hence, shorter adaptation 
time constant could cause short cycle PAN.  Short cycle PAN has been previously 
reported in subjects with A-T [25]. 
4-AP did not affect VOR gain measured during rotations along any axis.  These 
results are similar to the recent study where 4-AP was injected locally within the 
cerebellar flocculus or subcutaneously in tottering mice featuring CACNA1A mutation 
[27]. In healthy humans too, the pharmacological manipulations of the velocity storage 
are known to spare the VOR gain [10, 26]. The VOR gain reflects the state of direct 
pathway featuring three-neuron-arc [3].  Therefore our results are consistent with 
previous studies and suggest that effects of 4-AP to modulate VOR function is 
selectively via the velocity storage.   
 By diminishing the inward rectifying potassium conductance of an action 
potential, 4-AP is thought to increase pre-synaptic quantal content across a broad range 
of central and peripheral neurons. In disease states where neuronal dropout diminishes 
input to targets below excitation threshold, this action may partially restore selective 
function. This action is likely possible only over a narrow range of pathology, and hence 
those with severe degeneration may not manifest improved function. 
Our experience with just four subjects having A-T, over a short duration, in a 
focused neurologic function where available outcome assessment is sensitive and 
reliable, is nonetheless sufficiently encouraging to suggest that further testing of 4-AP is 
  
warranted. These studies, with other outcome measures, over a longer interval of 
treatment to access other mechanisms of action, with similar agents having better 
pharmacokinetics, or a combination of these and other protocol modifications, may well 
demonstrate a broader range of favorable effects.  
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Figure legends: 
Figure 1 Vestibular nystagmus is evoked during (rotational nystagmus) and after (post-
rotational nystagmus) constant velocity en bloc rotation in complete darkness. Rotations 
in the horizontal plane (yaw rotations) pre-dominantly evokes horizontal nystagmus, 
rotations in coronal plane (roll rotations) evokes torsional nystagmus, while sagittal 
plane rotations (pitch rotations) cause vertical nystagmus. Slow-phase velocity of the 
per-rotatory nystagmus is plotted versus time. (A) Gray symbols illustrate slow phase 
eye velocity of the horizontal rotational nystagmus. Notice a rapid rise followed by a 
slow exponential decay of the slow phase eye velocity of the nystagmus. The decay 
time constant of the rotational nystagmus in the given example was 11 seconds. The 
open circles represent the slow phase eye velocity of the horizontal rotational 
nystagmus, 30 minutes after the same subject took 10 mg 4-AP by mouth. After 
administration of 4-AP, the decay time constant of the rotational nystagmus in this 
subject reduced to 8 seconds. (B) Slow phase eye velocity of the torsional rotational 
nystagmus is illustrated with grey symbols. Administration of 4-AP did not alter the 
decay time constant of the torsional rotational nystagmus (Before 4-AP: 6.8 seconds; 
after 4-AP: 6.5 seconds). (C) The decay time constant of the slow phase eye velocity of 
the vertical rotational nystagmus also remained unchanged on administration of 4-AP 
(Before 4-AP: 6.2 seconds; after 4-AP: 6.2 seconds). 
 
Figure 2 Effects of 4-AP on the decay time constant of the per- and post-rotational 
nystagmus in three A-T subjects are summarized. The decay time constant of per- and 
post-rotatory nystagmus before 4-AP is plotted versus after 4-AP. (A) The decay time 
  
constant of the per- and post-rotational horizontal nystagmus from two subjects was 
significantly reduced by administration of 10 mg 4-AP (One-way ANOVA, p < 0.05). 
Notice square and circular symbols are below the equality line. However, 4-AP did not 
change the horizontal rotational nystagmus in one subject (One-way ANOVA, p > 0.05). 
This subject is illustrated as triangular symbols. Notice all triangles fall along the 
equality line. (B, C) In all three subjects, there was no significant reduction in the decay 
time constant of torsional and vertical rotational nystagmus as these subjects took 10 
mg 4-AP (One-way ANOVA, p> 0.05). Notice all symbols representing the decay time 
constant of torsional rotational nystagmus (B) and vertical rotational nystagmus (C) all 
along the equality line.  
 
Figure 3 Effects of 4-AP on VOR gain. The values of VOR gain before 4-AP is plotted 
on x-axis while y-axis depicts VOR gain after 4-AP.  Each datapoint depict one 
rotational trial, while each symbol type represent rotational plane. Dashed line is the 
equality line. All data point fall along equality line. Values of VOR gain before and after 
4-AP relate with correlation coefficient at 0.89 and slope of linear fit at 0.91.  
 
Figure 4 Effects of 4-AP on the peak velocity of the periodic alternating nystagmus 
(PAN) in two A-T subjects. The slow-phase horizontal eye velocity is plotted versus 
time. A sinusoidal pattern of the slow phase eye velocity is consistent with periodic 
alternating nystagmus. Black symbols represent the slow phase eye velocity before 4-
AP, while the grey symbols represent the slow phase eye velocity recorded 
approximately 30 minutes after the subjects took 10 mg 4-AP by mouth. 4-AP 
  
significantly reduced the peak slow phase horizontal eye velocity in one subject, while it 
completely abolished PAN in the other.  
 
Figure 5 The slow-phase eye velocity of spontaneous horizontal, vertical, and torsional 
nystagmus when A-T subjects fixated gaze on the central (straight-ahead) target. Black 
box and whisker plots summarize the slow phase eye velocity before administration of 
4-AP, while grey box and whisker plots represent the slow phase eye velocity recorded 
30 minutes after these subjects took 10 mg 4-AP by mouth. Horizontal bar in the center 
of the box and whisker plot represent median slow phase eye velocity, while notches 
represent 95% confidence interval around median. If notches from two box and whisker 
plot do not overlap, the difference between their medians is statistically significant (One-
way ANOVA, p<0.05). In most subjects, 4-AP significantly reduced the slow phase eye 
velocity of horizontal and vertical nystagmus, but torsional nystagmus was unaffected. 
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